Decreased production of butyric acid by colonic carbohydrate fermentation may predispose to colonic carcinogenesis, with the implicit assumption that the decrease in faecal butyrate found predates the development ofthe tumour. The influence of the genetic predisposition to colonic tumours and the presence of colonic polyps on in vitro fermentation of carbohydrates was examined. Stool samples from 11 normal controls and 20 patients with familial adenomatous polyposis (FAP) were incubated anaerobically with a range of carbohydrates. Fermentation patterns were similar for glucose and raffinose. These sugars produced different short chain fatty acid (SCFA) patterns from the two polysaccharides, starch and arabinogalactan, which differed one from the other. The FAP gene carriers with polyps produced less butyrate than normal controls (p<0005) and gene carriers without polyps (p<0 05). There were corresponding decreases in the molar ratios of butyrate. Gene carriers without polyps produced less absolute amounts of acetate than normal controls (p<0.05) and slightly less total SCFAs (p<0 05) but were otherwise not significantly different. The decreased production of butyrate noted by other workers may be secondary to the tumours rather than a contributory cause.
Epidemiology has stressed the importance ofdiet in the development of colorectal cancer. Diets high in complex carbohydrates seem to be protective, whereas those high in fat may have adverse effects.'2 Despite this epidemiological evidence, the importance of diet remains unproved and possible mechanisms have been sought. Burkitt originally suggested that the increased faecal bulk and decreased transit time associated with a diet rich in plant cell walls (dietary fibre) diluted carcinogens and lessened the contact time with the colonic mucosa. ' The realisation that dietary fibre is fermented in the colon to short chain fatty acids (SCFAs) has led to alternative hypotheses. 4 The production of SCFAs is associated with a reduction in pH that has been proposed to be a protective factor through an, as yet, uncertain mechanism.5 Also, attention has focused on butyric acid, one of the SCFAs, which has antineoplastic properties in vitro. 6 When added to malignant cell lines, butyrate is associated with the return of contact inhibition7 and the recovery of the morphological and functional characteristics associated with the parent cell.8 Decreased molar ratios of butyrate have been found in enema samples9 and in the faeces of patients with colonic cancers and polyps.'°Decreased butyrate production was reported in similar patient groups." It has therefore been hypothesised that dietary fibre is protective by virtue of its production of butyric acid.'
For this hypothesis to be tenable, the reduction in butyrate must predate the development of tumours. We attempted to test this hypothesis with subjects with familial adenomatous polyposis (FAP). As subjects can be identified before polyps develop,'2 it is possible to separate changes that predate polyp growth from those that appear after polyps develop.
Patients and methods

SUBJECTS
Thirty one subjects were recruited from the Northern Region Polyposis Registry. Table I shows that risk analysis allowed the patients to be divided into three groups. All gene carriers with polyps had a colonoscopy as had seven of 10 gene carriers with no polyps. The remainder of the second group had rigid sigmoidoscopy. One of the controls had colonoscopy and eight had rigid sigmoidoscopy. Two controls (ages 9 and 11) were children of a departmental member and were not endoscoped. No patient had received any antibiotics in the six weeks before the study. All subjects were on a mixed western diet and no dietary restrictions were imposed.
With the estimates of interindividual variation and between group differences in butyrate molar ratios given by Weaver et Also, where different substrates (glucose, raffinose, starch, and arabinogalactan) were used for in vitro incubations and tested within each subject, substrate effects were treated as a subplot. Hypotheses concerning differences between substrates and possible group x substrate interactions were tested by orthogonal contrasts (Table II) . The contrast arabinogalactanx other carbohydrates was also tested.
Results
THE EFFECT OF ANAEROBIC STORAGE FOR SIX HOURS ON FAECAL SCFAS
Four separate stool samples from the same donor were stored at 4°C for six hours. Storage had no effect on the absolute amounts of molar proportions of SCFAs in faecal samples over a six hour period (Tables III and IV (Table VIII) . There were no differences in faecal pH. Comparison of SCFA production by the different subject groups showed considerable differences (Table IX, Fig 3) . Compared with normal controls, gene carriers without polyps produced less total SCFA (p=0-016) with a reduction in the absolute amount of acetate (p=0 01) but no Table  IX and significance values arefrom ANOVA and orthogonal contrasts.
in the faeces and approximately 300 mmol a day are produced.'8 They are important in salt and water absorption from the colon,'9 and butyric acid, one of the SCFAs, is the most important respiratory fuel for the colonic mucosa. 8 The reduction in pH associated with the production of SCFAs has been proposed as a protective factor5 as a higher faecal pH has been noted in high risk populations.20 Some studies have shown high faecal pH in persons with colonic cancer,2' although others have failed to confirm these findings. 22 We detected no differences in faecal pH in our three subject groups suggesting that neither the FAP gene nor the presence of polyps influences faecal pH.
Interest has recently focused on the role of butyric acid in the development of colonic cancer. This compound has antineoplastic properties in vitro' and decreased molar proportions have been found in faecal and enema samples from patients with colonic cancers and polyps. Polyps also seem to affect the fermentation patterns of carbohydrates. The changes in SCFAs associated with polyps in our study are similar to those noted by other workers in enema9 and faecal samples'" and with in vitro models." It is possible that the changes noted by these workers were secondary to the presence ofpolyps rather than a contributory factor in their development. Alternatively the FAP gene carriers may be a heterogeneous group in which the early appearance of polyps is linked with reduced colonic butyrate. We showed no correlatioil between the age of onset of polyps and the faecal butyrate or the in vitro production of butyrate. This might be tested through a prospective study in which FAP gene carriers without polyps are divided into high and low butyrate groups and followed up until polyps develop.
Clausen et al considered the problem of causality by studying patients with sporadic neoplasms after colonic resection or endoscopic polypectomy and showed a reduction in the velocity of production of butyrate in affected patients." As the tumours had been removed it is not immediately possible to ascribe their results to an effect of polyps or cancers. All their subjects, however, had undergone bowel purgation, colectomy, or endoscopic polypectomy. The influence of these procedures on the microbial activity is not known and this difference in experimental protocol may explain the apparent disagreement with our results.
In conclusion we have identified different fermentation patterns in persons with FAP and an effect of polyps on the in vitro fermentation of carbohydrates. Furthermore 
